REAL-WORLD OBSERVATIONAL STUDY REGARDING GLUCOSE CONTROL IN INSULIN TREATED DIABETES MELLITUS PATIENTS. GLUCOSE VARIABILITY PATTERNS ANALYSIS USING CONTINUOUS GLUCOSE MONITORING SYSTEM (CGMS)

被引:0
作者
Popoviciu, Mihaela Simona [1 ,2 ]
Vesa, Cosmin [1 ,3 ]
Jurca, Aurora [3 ]
Jurca, Claudia [3 ]
Popa, Loredana [1 ]
Zaha, Dana [1 ,3 ]
Ceavoi, Gabriela [4 ]
Jurca, Alexandru [3 ]
机构
[1] Clin Cty Emergency Hosp Oradea, Oradea, Romania
[2] Univ Oradea, Fac Med & Pharm, Med Dept, Oradea, Romania
[3] Univ Oradea, Fac Med & Pharm, Dept Preclin Disciplines, Oradea, Romania
[4] Univ Oradea, Fac Med & Pharm, Dent Med Dept, Oradea, Romania
关键词
diabetes mellitus; insulin therapy; continuous glucose monitoring; GLYCEMIC CONTROL; TYPE-2; HYPOGLYCEMIA; ANALOGS; BASAL; MANAGEMENT; INJECTION; GLARGINE; EFFICACY; ADULTS;
D O I
10.31925/farmacia.2021.2.19
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study there were evaluated 167 diabetes mellitus patients treated with insulin (without treatment with other oral antidiabetics or other non-insulin injectable antidiabetics) from the Clinical County Hospital of Oradea, Romania in terms of the prescribed insulin therapy (IT) regimen: long-acting (basal) insulin analogues, long-acting insulin analogues and rapidacting (prandial) insulin analogues or premixed insulin and the impact of the IT regimen on the glycaemic control determined by glycosylated haemoglobin (HbA1c). 35.11% of those with basal IT (n = 92), 32.69% of those with basal and prandial IT (n = 52) and 28.57% of those with premixed IT (n = 21) reached a moderate glycaemic control (HbA1c < 7.5%) without any statistically significant differences (p = 0.84). 12 patients were selected by systematic sampling and evaluated for 6 - 8 days by inserting a continuous blood glucose monitoring system (CGMS) in a private practice healthcare office. It was found that in 72% of the monitoring period patients are outside the target glycaemic range of 70 - 150 mg/dL because of hyperglycaemic excursions, in 26% they fell within the therapeutic range and in 2% they were outside the range because of hypoglycaemic excursions. The frequency of hypoglycaemia was high, 50%, but the majority were mild hypoglycaemias and the time spent in hypoglycaemia was extremely short. Therefore modern IT is safe in terms of the risk of hypoglycaemia but glycaemic control is rarely achieved. Hyperglycaemic excursions as demonstrated by CGMS data cannot be explained as hyperglycaemia consecutive to hypoglycaemia.
引用
收藏
页码:332 / 340
页数:9
相关论文
共 40 条
  • [1] [Anonymous], 2010, DIABETES CARE, DOI DOI 10.2337/dc10-S011
  • [2] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [3] Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
    Beck, Roy W.
    Bergenstal, Richard M.
    Riddlesworth, Tonya D.
    Kollman, Craig
    Li, Zhaomian
    Brown, Adam S.
    Close, Kelly L.
    [J]. DIABETES CARE, 2019, 42 (03) : 400 - 405
  • [4] The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial Comparing the durability of lispro mix 75/25 and glargine
    Buse, John B.
    Wolffenbuttel, Bruce H. R.
    Herman, William H.
    Hippler, Stephen
    Martin, Sherry A.
    Jiang, Honghua H.
    Shenouda, Sylvia K.
    Fahrbach, Jessie L.
    [J]. DIABETES CARE, 2011, 34 (02) : 249 - 255
  • [5] Insulin Analogs-Is There a Compelling Case to Use Them? No!
    Davidson, Mayer B.
    [J]. DIABETES CARE, 2014, 37 (06) : 1771 - 1774
  • [6] The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges
    Davies, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (Suppl 2) : S14 - S22
  • [7] Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department
    Dobrica, Elena-Codruta
    Gaman, Mihnea-Alexandru
    Cozma, Matei-Alexandru
    Bratu, Ovidiu Gabriel
    Stoian, Anca Pantea
    Diaconu, Camelia Cristina
    [J]. MEDICINA-LITHUANIA, 2019, 55 (08):
  • [8] Real-life glycemic control in patients with type 2 diabetes treated with insulin therapy: A prospective, longitudinal cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 9])
    Fujita, Naotaka
    Yamamoto, Yosuke
    Hayashino, Yasuaki
    Kuwata, Hirohito
    Okamura, Shintaro
    Iburi, Tadao
    Furuya, Miyuki
    Kitatani, Masako
    Yamazaki, Shin
    Ishii, Hitoshi
    Tsujii, Satoru
    Inagaki, Nobuya
    Fukuhara, Shunichi
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 294 - 302
  • [9] Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
    Gabbay, Monica Andrade Lima
    Rodacki, Melanie
    Calliari, Luis Eduardo
    Vianna, Andre Gustavo Daher
    Krakauer, Marcio
    Pinto, Mauro Scharf
    Reis, Janice Sepulveda
    Punales, Marcia
    Miranda, Leonardo Garcia
    Ramalho, Ana Claudia
    Franco, Denise Reis
    Pedrosa, Hermelinda Pedrosa Cordeiro
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
  • [10] Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity
    Gaman, Mihnea A.
    Dobrica, Elena C.
    Pascu, Emilia G.
    Cozma, Matei A.
    Epingeac, Mirela E.
    Gaman, Amelia M.
    Stoian, Anca P.
    Bratu, Ovidiu G.
    Diaconu, Camelia C.
    [J]. JOURNAL OF MIND AND MEDICAL SCIENCES, 2019, 6 (01): : 157 - 161